In this episode, your host, Jordan Burgin, is joined by Brandon Allen a cardiovascular commercial leader who is CCO at Atraverse Medical, the transseptal-access company acquired by Johnson & Johnson to talk about what it really takes to commercialise cardiovascular technology.
Drawing on two decades across Guidant, Boston Scientific, Biosense Webster, Acutus and Atraverse, Brandon shares the lessons that don’t make the pitch deck: surviving a cash crisis with three months of runway left, choosing between VC and family-office capital, building electrophysiology teams from scratch, and why the first commercial hire can decide whether a startup makes it.
Key Topics
Brandon’s accidental path into medtech and cardiac EP from college golf to Pfizer to Guidant
Surviving a cash crisis with three months of runway left
VC capital vs. family-office capital for cardiovascular startups
Building and developing commercial teams in electrophysiology
What early adoption really takes in the EP lab, the “aha moment”
When to make your first commercial hire and who it should be
Related Insights
Why family offices can beat VCs on founder control and connection
Selling the patient story, not just the clinical data
Why engineers need to be in the room during live cases
How leaders learn more from bad leadership than good
Core Challenges
Founders confuse clinical validation with commercial adoption, underestimating how entrenched the big four (Biosense, Medtronic, Abbott, Boston) already are inside hospitals.
Companies wait until approval to hire sales talent, forgetting it can take 90–180 days before a new rep delivers any revenue making the timing, and the first hire, mission-critical.
🎧 Tune in now to hear how Brandon Allen turns differentiated cardiovascular technology into real commercial traction, from cash crises to clean exits.
The Crux of MedTech podcast is brought to you by Cruxx, a specialist surgical robotics recruitment agency.
To learn more about Cruxx, click here.
A big thank you to our sponsors on this season of the podcast;
TTP plc With a 35-year track record, TTP excels in turning innovative ideas into market-ready solutions. Their team of 300+ experts deliver breakthrough solutions in areas ranging from endoluminal robotics and navigation systems to ultrasound imaging. Whether you're a startup or a multinational, TTP plc can accelerate your development with the latest technologies. Learn more at TTP.com
Information
- Show
- FrequencyUpdated fortnightly
- Published17 July 2026 at 05:00 UTC
- Length58 min
- RatingClean
